This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Jan Barnikow in Biotechnology
Introduction
Jan Barnikow is a notable inventor based in Basel, Switzerland, recognized for his groundbreaking work in biotechnology. With a single patent to his name, he has made significant strides in the field of protein engineering, demonstrating innovative approaches to enhancing the stability and reactivity of key proteins.
Latest Patents
Jan Barnikow's patent revolves around engineered AGT (O6-alkylguanine-DNA alkyltransferase) mutants, which display several advantageous properties in comparison to the wild type human AGT. These properties include reduced DNA interaction, improved expression yields as soluble proteins, and enhanced stability under various conditions. His work outlines specific mutations involving the substitution, deletion, or addition of amino acids, resulting in AGT mutants that are particularly useful in fusion protein applications. This innovation opens up new possibilities in detecting and manipulating proteins of interest.
Career Highlights
Barnikow currently works at the Ecole Polytechnique Fédérale de Lausanne, a prestigious institution where he is involved in cutting-edge research in biotechnology. His career has been characterized by a dedication to advancing the understanding and application of protein dynamics, contributing to both scientific literature and practical applications in biomedicine.
Collaborations
Throughout his career, Jan Barnikow has collaborated with notable colleagues, including Christopher Chidley and Thomas Gronemeyer. These partnerships reflect a commitment to interdisciplinary research and the sharing of expertise, which is crucial for driving innovation in the rapidly evolving field of biotechnology.
Conclusion
Jan Barnikow’s contributions to the scientific community through his patent and research have paved the way for advancements in protein engineering. By enhancing the functionalities of AGT mutants, he is not only addressing existing challenges in protein interaction and stability but also setting the stage for future innovations in therapeutic and diagnostic applications. His work exemplifies the critical role of inventors in shaping the future of biotechnological advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile